Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TAK1/MAP3K7 is an essential signal transducer integrating pro-inflammatory cues into cellular outcomes that govern immunity, development, tissue remodeling—and when dysregulated—disease pathogenesis across multiple organ systems. It is activated by various stimuli including TGF-beta, IL-1, TNF-alpha and TLRs and regulates downstream signaling pathways such as NF-kappaB and JNK/p38 MAPK.
Inhibition of TAK1 kinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transforming Growth Factor-beta Activated Kinase 1 (TAK1).